Gopala Krishna Dasari

Title: Gopala Krishna Dasari: Innovator in Pharmaceutical Chemistry

Introduction

Gopala Krishna Dasari is a notable inventor based in Vizianagaram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for cancer treatment. With a total of 2 patents, his work has the potential to impact the medical community positively.

Latest Patents

Dasari's latest patents include innovative formulations that enhance the efficacy of cancer treatments. One of his notable inventions is the "Polymorphs of Ribociclib mono succinate," which relates to novel crystalline and amorphous polymorphic forms of Ribociclib mono succinate. These crystalline forms may be useful in the improved preparation of oral dosage forms for the treatment of cancer. Another significant patent is the "Process for the preparation of ibrutinib," which details a method for producing highly pure Ibrutinib, a compound used in cancer therapy.

Career Highlights

Throughout his career, Gopala Krishna Dasari has worked with reputable companies, including Shilpa Medicare Limited and Shilpa Medicare Limited. His experience in these organizations has allowed him to refine his skills and contribute to important pharmaceutical advancements.

Collaborations

Dasari has collaborated with several professionals in his field, including Chanti Babu Patneedi and Sriram Rampalli. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.

Conclusion

Gopala Krishna Dasari's contributions to pharmaceutical chemistry through his patents and collaborations highlight his commitment to advancing cancer treatment. His work exemplifies the importance of innovation in the medical field, and his inventions may lead to improved therapeutic options for patients.